QUOTE AND NEWS
Business Wire  Apr 2  Comment 
Tortoise MLP Fund, Inc. (NYSE: NTG) today announced that as of March 31, 2012, the company’s unaudited total assets were approximately $1.7 billion and its unaudited net asset value was $1.2 billion, or $25.51 per share. As of March 31, 2012, the
The Hindu Business Line  Mar 12  Comment 
Hyderabad firm to sell the drug at Rs 8,880/month; to pay Bayer 6% of net sales as royalty
The Hindu Business Line  Mar 12  Comment 
Natco's baby step may pave the way for a giant leap of sorts, where many more drug patents are subjected to this “stick” to help bring down highly excessive prices for a country like India, says M...
The Economic Times  Feb 9  Comment 
Natco Pharma today reported a 23.91 per cent increase in its consolidated net profit at Rs 17 crore for the quarter ended December 31, 2011.
The Hindu Business Line  Feb 9  Comment 
Natco Pharma has registered a net profit of Rs 17 crore for the quarter ended December 31, 2011, marginally up from Rs 15.94 crore in the comparative quarter. According to unaudited...
The Hindu Business Line  Jan 17  Comment 
Natco Pharma Ltd will commence production at its exclusive facility for manufacturing Galtiramer Acetate for Mylan Inc. soon. ``The Rs 91 crore dedicated facility set up here under an ag...
The Economic Times  Dec 18  Comment 
As part of its marketing strategy, Natco has tied up with leading companies such as Mylan, Dr Reddy's Labs, Actavis, Breckinridge and Lupin.
The Hindu Business Line  Dec 14  Comment 
Natco Pharma Ltd has allotted equity shares of the company to the investors in its recently concluded qualified institutional placement (QIP) for Rs 67.5 crore.The allotment was done...
Reuters  Dec 8  Comment 
Drugmaker Natco Pharma said on Thursday it has raised 675 million rupees through share sale to qualified institutional buyers on December 7.
The Hindu Business Line  Nov 9  Comment 
Natco Pharma Ltd's net profit increased 9 per cent to Rs 16 crore in the second quarter ended September 30 compared with Rs 14.72 crore in the corresponding quarter of previous yea...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki